Tags Posts tagged with "list of marijuana stocks"

list of marijuana stocks

0 1200

OTTAWA, ONTARIO–(Marketwired – Jun 14, 2017) – Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (CSE:TBP)(TBP.CN)(CNSX:TBP)(TBPMF) today announced that it has appointed Mr. Carl A. Merton to the Board of Directors, effective immediately.

Mr. Merton has over 20 years of financial and business experience, including 10 years experience as a CFO for public companies involved in the capital markets. Beginning with 12 years combined with Ernst & Young and KPMG, he transitioned from the audit stream into financial advisory work, as a Business Valuator, Forensic Accountant and Corporate Finance functions. After leaving KPMG, Mr. Merton joined Atlas Tube Inc., as Vice-President, Special Projects. After assisting in the sale of Atlas Tube, Mr. Merton became the CFO of Reko International Group Inc. In December 2014, Mr. Merton was elected by shareholders as a member of the inaugural Board of Directors of Aphria Inc. Approximately one year later, Mr. Merton resigned as a member of the Board and joined Aphria as its CFO. In his role as CFO, Mr. Merton is responsible for communication with all stakeholders and is a member of the executive management team responsible for the strategic direction of Aphria, as well as leading all acquisition discussions, budgeting, financing, financial reporting and internal controls. Mr. Merton is a Chartered Professional Accountant, a Chartered Accountant and is a Fellow of the Canadian Institute of Chartered Business Valuators (the “CICBV”). He holds a B.Comm. Hon. in Sports Administration from Laurentian University, and has served as a past Chair of both the CICBV and the International Association of Professional Business Valuators. Mr. Merton is currently a member of the Board of Directors and Chair of the Audit Committee of Motor City Community Credit Union.

“We are most pleased to welcome Mr. Merton to the board as we continue to work closely with our strategic partner, Aphria in building Tetra as a leading bio-pharmaceutical organization,” said Andre Rancourt, Chairman and CEO of Tetra Bio-Pharma. “Mr. Merton’s tremendous experience as a CFO of publicly listed companies has resulted in raising in excess of $200 million. His vast network both in the U.S. and Canada will be a key factor in the Company’s growth. We look forward to working closely with him in building Tetra as a global leader in pharmaceutical cannabis.”

About Tetra Bio-Pharma:
Tetra Bio-Pharma is a multi subsidiary publicly traded company (CSE:TBP)(TBPMF) engaged in the development of Bio Pharmaceuticals and Natural Health Products containing Cannabis and other medicinal plant based elements.

Tetra Bio-Pharma is focused on combining the traditional methods of medicinal cannabis use with the supporting scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators physicians and insurance companies. More information is available about the company at: www.tetrabiopharma.com.

Source: Tetra Bio-Pharma

The Canadian Securities Exchange (“CSE”) has not reviewed this news release and does not accept responsibility for its adequacy or accuracy.

Forward-looking statements

Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company, through its wholly-owned subsidiary, GrowPros MMP Inc., to obtain a licence for the production of medical marijuana; failure to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

0 3496
Marijuana-stocks-biotech

Marijuana stocks continue to trade volatile and Tetra Bio Pharma (TBP.CN) (TBPMF) has been one of the top performers recently. The shares rallied 22% last week and Tetra is well positioned to move significantly higher.

We recently highlighted Tetra Bio and want to provide an update on the company after last week’s move higher.

Continues to Strengthen Management Team

One of the major focuses of Tetra this year has been on its management team and earlier this month, the company added Dr. Bill Cheliak to its Board of Directors.

Dr. Cheliak is CEO of Panag Pharma, a Canadian based bio-tech company focused on the development of novel cannabinoid based formulations for the treatment of pain and inflammation. He has over 20 years of experience as an entrepreneur and brings extensive deal making experience to the company. Dr. Cheliak currently serves as a Director for Solarvest and is Vice Chair of the Government of Canada’s Networks Centers Excellence Standing Selection Committee and Chair of the NCE Monitoring Committee.

Earlier in May, Tetra Bio further strengthened its management team after it announced that Robert Bechard was appointed to the position of Vice President, Finance and Business Development.

A Focus on Cannabis Biotech Treatments

The addition of Dr. Bill Cheliak to the Board comes one-week after Tetra Bio signed a definitive agreement with Panag Pharma for the development and commercialization of novel cannabinoid based formulations for the treatment of pain and inflammation.

Per the definitive agreement, Tetra will have exclusive access to sell the ocular and topical drug products in North America with right of first negotiation for outside U.S. and Canadian territories. In addition, Tetra has a right of first negotiation for future cannabinoid-based products.

Tetra will work in close collaboration with Panag’s team of experts to ensure a rapid and successful development leading to marketing authorization. Panag will continue work in the development of novel products for unmet medical need and Tetra will take the lead in commercializing these novel drug products.

Positioned to Execute

The signing of a definitive agreement follows the submission of a provisional patent application with the U.S. Patent and Trademark Office (USPTO) for a pharmaceutical drug formulation to treat various forms of cancer and ocular disease

Tetra is focused on developing cannabinoid based pharmaceutical treatments for indications that are multi-billion-dollar opportunities and we think these steps have significantly improved the company’s position within the biotech sector. This is a stock to watch and one we suggest putting toward the top of your radar screens.


 

Disclaimer: Pursuant to an agreement between MAPH and Tetra Bio-Pharma, we were hired for a period of 90 days to publicly disseminate information about (TBPMF) including on the Website and other media including Facebook and Twitter. We are being paid $75,000 (CASH) for and were paid 250,000 restricted common shares of Tetra Bio-Pharma. We may buy or sell additional shares of (TBPMF) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

0 1362

5 Benefits Of CBD

The emergence of the legal cannabis industry has created an unprecedented opportunity for investors. Although this burgeoning industry is already a multi-billion-dollar business, it is not even in the first inning of what will be multi-decade growth super cycle.


Click Here Now To Read Full Article


PotNetwork Holding, Inc. (POTN) : SeeThruEquity Initiates Coverage, Price Target of $0.25

PotNetwork Holding, Inc. (OTC PINK: POTN) is pleased to announce today that following the presentation at the 6th Annual SeeThruEquity’s Micro Cap Investor Conference, PotNetwork and Diamond CBD have been the highlight of a recent comprehensive research report projecting a price target of $0.25.


Click Here Now To Read Full (POTN) Release


 

Will Early Recreational Marijuana Sales Be A Reality for Nevada

Nevada’s idea of using its medical marijuana market to temporarily aid to the need of the recreational sector is set to launch sometime within the next month. Taken from a report from the Las Vegas Sun, there are more than 140 applicants vying to become the first to sell weed in a manner similar to beer.


Click Here Now To Read Full Article


 

mCig Inc. (MCIG ), Player’s Network, Inc. (PNTV ) Complete Phase 1 Construction for Production Facility

mCig Inc., ( OTCQB : MCIG ), a leading distributor of innovative products, technologies, and services for the global medical cannabis industry and Player’s Network, Inc. ( OTCQB : PNTV ), a diversified holding company operating in media and marijuana, today announce the Phase 1 completion of Green Leaf Farms Holdings, facility in North Las Vegas.


Click Here Now To Read Full Release


 

0 1258

Canadian Cannabis & An Under The Radar Biotech Company

 

Millions of investors across the globe have had their eyes and investment dollars fixated on the Canadian cannabis industry for a myriad of reasons. For starters, medical marijuana is federally legal in Canada with the Trudeau administration signalling that the end goal is full scale legalization in a two prong approach of giving the people what they want and crippling the black markets. This progressive and pragmatic approach is what has investors in the United States salivating for as the consensus is that first mover advantage in an emerging market such as Cannabis will yield massive gains and fuel innovation in many different verticals within the industry. Still not convinced? Raise your hand if you were around for the Dot com era and investing (or aware of it for that matter), now raise your hand if you were around in the 1930’s and investing once prohibition ended. Cannabis and Marijuana Stocks are a once in a generation investment opportunity hands down!

 


Click Here Now To Read Full Article


PotNetwork Holding, Inc. (POTN) Diamond CBD to be Featured at SeeThruEquity’s Conference

PotNetwork Holding, Inc. (OTC Pink: POTN) is pleased to announce today that it will attend SeeThruEquity’s Annual Micro Cap Investor Conference, June 1st in New York City, where it will showcase its wholly owned subsidiary, Diamond CBD, Inc. Presenting on behalf of the Company will be its newly appointed Chief Consultant for Special Projects, Bruce Barren.

 


Click Here Now To Read Full (POTN) Release


Marijuana Policies Being Reworked In 5 Countries

 

Marijuana policy isn’t something that’s just impacting the United States. Here’s what’s happening across the globe in 5 other countries working to implement in the nea-term

 

 


Click Here Now To Read Full Article


0 2052
marijuana-stocks-north-america-cannabis

The cannabis sector continues to heat up and from earnings to acquisitions, from partnerships to insider selling, there are a number of developments investors need to be aware of.

Although we are seeing cannabis reform all over the globe, North America has been at the epicenter of such activity for the last few years. The industry incredible growth has led to creation of new sub-industries as well as opportunities.

A Differentiated and Massive Opportunity

One of the new opportunities that has taken the market by storm is Cannabis Wheaton (CBW.V) (KWFLF) and today, one of the company’s streaming partners announced a corporate update comprised of several significant developments.

Cannabis Wheaton recently released its list of streaming partners and one of them, Beleave Inc. (BLEVF) (BE.CN: CSE) just received a cultivation license from Health Canada earlier. This is a milestone for both companies and it increases the number of streaming partners with a cultivation license to three (two partners have sales licenses)

Earlier this month, Beleave signed an agreement with Cannabis Wheaton to finance the purchase and construction of a second production facility in return for equity in a joint venture corporation and a production yield allocation of the new proposed site.

The new facility will be designed to accommodate 200,000 sq. ft. of cultivation space and this is a stock that investor should be keeping an eye on.

United Cannabis Reports Misleading Earnings

Earlier this month, United Cannabis Corp (CNAB) reported its financial and operating results for the period that ended on March 31st. We rarely report on this company and it is not because there is nothing to report on, but due to the lack of execution and poor communication.

When the company does have news to report, it is typically related to a member of the executive team (CEO, COO, or VP) selling stock. We wanted to provide an earnings highlight on United Cannabis to provide better insight into why we are cautious with the firm:

  • During the quarter, the company recorded an $815,976 net loss on $189,677 in revenue. United Cannabis reported a gross profit of $68,626 and a $519,600 loss from operations.
  • As of March 31st, United Cannabis reported to have $35,584 of cash on hand, a working capital deficit of $781,998, and an accumulated deficit of $10,216,055. The company also has over $550,000 worth of notes payable to management and accrued wages payable
  • In the report, the company discussed the insider selling and said the sellers re-invested a large portion of after tax proceeds ($178,383 and $71,007, during the past two quarters). The funds were used to pay obligations and expenses, and make advances in the amount of $135,971 to its Caribbean Research & Development Company, subsidiary in Jamaica.

The Management Team is Not Always the Best Indicator

Despite having a former Presidential candidate and former state Senator involved with the business, Cananbis Sativa remains one of the worst opportunities in the sector.

Earlier this week, Cannabis Sativa (CBDS) reported its financial and operating results for the period that ended on March 31st. Their earnings results were somewhat comical as we do not understand how anyone can invest in the company and consider it to be a long-term investment. Highlights from the report include:

  • During the quarter, Cannabis Sativa recorded a $2 million net loss on $1,065 in revenue. The company’s cost of revenue also exceeded the total revenue generated and CBDS reported a $34 gross loss.
  • Professional fees accounted for $1.82 million of the $2 million in operating expenses. The company said these fees were related to the development of business transactions and mostly were non-cash transactions.
  • As of March 31st, Cannabis Sativa reported to have $886,490 of cash on hand ($563,824 as of May 18th) and an accumulated deficit of $ $61,235,463.
  • The company continues to fund itself through the sale of stock and through private offerings. During the quarter, Cannabis Sativa generated $415,136 from the sale of stock and $356,100 from a private offering of stock.

 

 


Pursuant to an agreement between MAPH and Cannabis Wheaton (KWFLF) we were hired for 30 Days to publicly disseminate information about (KWFLF) including on the Website and other media including Facebook and Twitter. We are being paid $150,000 (CASH) for and were paid “0” shares of restricted common shares of Cannabis Wheaton. We may buy or sell additional shares of (KWFLF) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

marijuana-stocks-canadian-cannabis-

The Canadian stock market was closed for Victoria Day yesterday and today, three marijuana stocks reported several significant developments. We have highlighted these developments below to help you focus on important trends sweeping the industry.

New Cannabis IPO to Raise $50+ Million

One of newest and most differentiated Canadian cannabis producers, Cannabis Wheaton (CBW.V: TSX Venture) (KWFLF) announced a $50 million private placement and engaged a syndicate of agents co-led by Eight Capital and Canaccord Genuity.

The firm is selling special warrants and convertible debenture units and will use the net proceeds for general corporate purposes, for the financing of its streaming partners pursuant its streaming agreements, and for general and administrative expenses.

Cannabis Wheaton is off to a great start after the company reported that MMCAP International Inc. SPC intends to subscribe for up to $20,000,000 of the offering. The offering is expected to occur on June 21st and the company granted the underwriters an over-allotment option which increases the offering to $57.5 million.

Cronos’ Breaks Ground on a Brand New 315,000 sq. ft. Facility

Today, Cronos Group’s (MJN.V: TSX Venture) (PRMCF) wholly-owned licensed producer, the Peace Naturals Project broke ground on a 315,000 sq. ft. expansion that includes a 286,000 sq. ft. production facility, a 28,000 sq. ft. greenhouse, and an additional 1,200 sq. ft. extraction lab.

Upon completion, the facility is expected to be the largest purpose-built indoor cannabis production facility in the world. The facility is expected to complete by November and fully operational by summer 2018. This expansion will bring Peace’s total estimated production capacity to 40,000 kg a year.

The facility is designed to GMP certification standards and will include:

  • An area for proprietary genetic breeding
  • Pharma lab for cannabinoid and terpene extraction, identification, and formulation
  • R&D space for analyzing metabolite enhancement and new lighting technologies
  • Tissue culture laboratory
  • Industrial-grade kitchen
  • Processing infrastructure that supports production from other facilities

Cronos is breaking ground on the greenhouse today and the facility will be used to collect data and implement advanced cultivation techniques that can be replicated at its other production facilities. The company’s extraction lab will augment capabilities in both purification and recombination of cannabinoid compounds to create innovative formulated products. The greenhouse and lab are expected by the end of the summer.

Aurora to Supply Resources to Support a Groundbreaking Legal Case

Today, the Canadians for Fair Access to Medical Marijuana (CFAMM) reported an investment by Aurora Cannabis (ACB.V) (ACBFF) that is of a different nature than its prior investments.

CFAMM announced that Aurora has committed financial and other resources to support Gordon Skinner’s defense in what might be a potentially precedent-setting medical cannabis insurance coverage case. CFAMM has been providing strategic support to Skinner and Aurora’s resources will ensure that Skinner can defend his case.

On January 30th, the Nova Scotia Human Rights Commission ruled that the Board of Trustees of the Canadian Elevator Industry Welfare Trust Fund committed discrimination by denying coverage for the medical cannabis Skinner uses to manage chronic pain and other conditions resulting from a work-related injury that left him permanently impaired. Following the decision, the Board of Trustees filed an appeal against Skinner and the Commission in the Nova Scotia Court of Appeal. The appeal has been set for October 2, 2017.

Founded in 2014, Canadians for Fair Access to Medical Marijuana (CFAMM) is a federal non-profit, patient-run organization dedicated to protecting and improving the rights of medical cannabis patients. CFAMM’s goal is to enable patients to obtain fair and safe access to medical cannabis with a special focus on affordability, including private and public insurance coverage.

We want to commend Aurora on its commitment to improving the cannabis industry and supporting patients in need. This decision may have a lasting impact on the sector and could change the landscape of the Canadian medical cannabis industry.

 


Disclaimer: Pursuant to an agreement between MAPH and Cannabis Wheaton (KWFLF) we were hired for 30 Days to publicly disseminate information about (KWFLF) including on the Website and other media including Facebook and Twitter. We are being paid $150,000 (CASH) for and were paid “0” shares of restricted common shares of Cannabis Wheaton. We may buy or sell additional shares of (KWFLF) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

0 6016
Marijuana Stocks Cannabis Stocks

Marijuana Stocks, especially Cannabis Companies with strong ties to Biotech have been increasingly front and center on Wall Street’s main stage.  Marijuana Stocks and the Cannabis-Biotech sector continue to evolve and grow into the mainstream powerhouse we know it can and will be. We have identified a small Cannabis-Biotech start up that deserves your attention.

InMed Pharmaceuticals (IMLFF) is a Vancouver-based pre-clinical trial Cannabis-Biotech company that has not only developed a proprietary cannabinoid manufacturing system yet in the process created a highly sought after database, which has mapped the different compounds of cannabinoids to the various diseases that it can address.

This cannabinoid database was designed by (IMLFF) to assist them in their investigative studies and has currently become a core asset as other Cannabis Biotech companies have come knocking on their door willing to offer a hefty sum for this information. Most medical marijuana processors are using THC and CBD because they are easy to extract in large quantities, however there are more than 90 diverse cannabinoid structures that (IMLFF) has plugged into its system. The bioinformatics algorithm has taken those different compounds and screens them against approved drugs, diseases and genetic properties of diseases. It then selects specific cannabinoids that might help regulate that particular disease.

InMed Pharmaceuticals (IMLFF) has created this database “tool” & is saving time and money in the drug research process. It has already helped (IMLFF) to identify two treatments for rare diseases. One for a rare children’s skin disease called epidermolysis bullosa (EB) that has no approved treatments and the other for glaucoma. Chief Executive Officer Eric Adams said, “It’s a very devastating disease and we found out in early testing that this set of cannabinoids treat the major symptoms of this disease giving them a tremendous amount of relief, but it may also reverse the disease, which is something no one has really talked about before.”

Startup Cannabis-Biotechs like InMed Pharmaceuticals (IMLFF) will continue to grow as Marijuana Stocks / Sector continues to evolve into mainstream markets.

    0 2404

    Over recent weeks we’ve been shedding more light on the hemp industry and why we see it as an important part of the bigger cannabis space.  Marijuana Stocks, the Wolf of Weed Street and Cheryl Shuman have been working closely with FBEC Worldwide to help develop the first branded hemp infused energy drink for FBEC called the “Wolf Shot Hemp Energy.” The product launch is slated for August 1 and buzz has grown quickly.  Friday FBEC Worldwide was highlighted in an article on TheStreet.com, which focused specifically on the Hemp industry, what it is, why it’s important, and why investors should be paying much more attention to it now more than ever:

    “Hemp Won’t Get You High, But Could Boost Your Portfolio Sooner Than You Think”

    The article discusses the differences between hemp and marijuana citing that though they both are derived from the same type of cannabis plant, their uses couldn’t be more different. Major health benefits from hemp include higher levels of easily digestible protein, longer sustained levels of energy, improved mental focus and even reduction in cardiovascular disease.  The biggest benefit is that though it is limited to growing in the US, using and selling products that have it is not.  Highlighting FBEC Worldwide as a viable option for taking advantage of the growth that this space could see in both short and long terms adds much more legitimacy to the company and shows the true differences between companies planning to do something and companies actually doing it like FBEC Worldwide is; now 3 weeks away from initial product launch.

    Read the full article HERE

    0 1810

    While screening for drugs is not new, the legalization of recreational cannabis in states such as Washington, Oregon, Alaska, and Colorado has added a question mark for some workers and people trying to find employment. However recreational marijuana smokers may be held responsible and not allowed the use of cannabis to effect their work lives. Should they still be worried about company drug policies? Marijuana used on a weekend does not mean cannabis was used at work though present drug testing can’t tell the difference.

    A recent issue has been the strict way of drug screening and drug use policies in the work environment and how they possibly could be eliminating great prospective hires’ consideration, especially concerning zero tolerance policies that sometimes extend into the past. For instance, the CIA asks about the use of cannabis going as far back as 12 months prior to filling out an application while the FBI and some law enforcement agencies look as far back as 3 years.

    A zero tolerance system, something very common among employers thought America, automatically eliminates various prospects to hire who are fresh out of college and looking for employment. This is really causing an issue in states where recreational cannabis is currently legal. The concern is that zero tolerance policies are often identical to the federal Drug-Free Workplace Act of 1988 and the Drug-Free Schools & Communities Act Amendments of 1989, which are not entirely unreasonable but are starting to create an issue with state laws that are changing the federal stance on cannabis.

    OElB5ie

    Peter Cappelli, a professor of management at The Wharton School, looks at these policies as a hindrance to employers as well as the prospective employees, yet he does not feel they will be changed anytime in the near future, “My guess is that [companies will] just continue to suffer from it, that it’s harder to hire people, because it’s politically too difficult to explain.”

      0 2116

      Colorado-Based Blue Line Protection Group has opened a subsidiary to allow the company that ability to handle financial services for Marijuana companies. These include licensing and bookkeeping. Blue Line’s CFO, Patrick Deparini told the New York Daily News, “Our goal is to streamline and simplify the day-to-day bookkeeping duties these businesses face. By doing so, we reduce our clients’ operating costs, help ensure their compliance with the myriad local, state and federal regulations, and provide them with peace of mind with our guarantee of audit protection services.”

      Blue Line’s new business, Blue Line Advisory Services is pushing forward to become a legal liaison for the budding marijuana industry, which to this point has been mainly a “cash-only business”. Banks are still hesitant to take money from cannabusinesses. Despite this fact, Uncle Sam still needs his cut.

      In Colorado, the Denver IRS has set up a separate, Cash-only line and even though growing cannabis is deductible under the federal tax law, selling it is not and ends up putting business owners into higher tax brackets!

      For Blue Line Protection, their new finance focused business, Blue Line Advisory will look to become an integral part of the financial landscape of this expanding marijuana industry.

       

      Read More at New York Daily News

      Subscribe Now & Begin Receiving Marijuana Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

      We are your #1 source for all things Marijuana Stocks, Subscribe Below!

      Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on marijuana stocks related, articles, news and trade alerts. Further questions please contact privacy@marijuanastocks.com
      Ad Placements